The Steering Committee
Alastair Carruthers, MD, FRCP(C)
You need to upgrade your Flash Player
|
You need to upgrade your Flash Player to view this content.
What's New
|
• Interactive case study on volumizing with dermal fillers available now!
Our newest case study, developed with Steering Committee Member Mark L. Jewell, MD, explores treatment options for the off-label use of dermal fillers for mid-face volumizing. Upon completion of the case study, posttest, and evaluation form, you'll receive 1.0 AMA PRA Category 1 Credit instantly!
|
|
|
• New CME Webinar!
Current Concepts in Facial Aesthetics: Consensus Recommendations for Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) Fillers is a CME Webinar archive featuring Drs Steven Fagien, Steven Dayan, and Jessica Wu. Presentations focus on best practices for BoNTA and HA Fillers used alone and in combination for the upper, middle, and lower face.
|
|
|
• Updated Product Information page!
This comprehensive resource provides information on product indications, contraindications, and adverse events for botulinum toxins, dermal fillers, and topical creams used in aesthetic-enhancement procedures. Links to labeling information, US FDA advisories, and commentaries from our Steering Committee are also featured!
|
|
|
• Ask The Expert
Steering Committee Members Thomas E. Rohrer, MD, and Julius W. Few, MD, FACS, address questions regarding the use of botulinum toxin type A (BoNTA) for glabellar lines and crow's feet (off label); injection techniques for non–animal-stabilized hyaluronic acid; and treatment strategies for keloids, among other topics.
|
|
|
• Clinical Literature Overviews
The latest current literature entries explore complications after the use of polymethylmethacrylate injections, results from the Injectable Filler Safety (IFS) study, and the effects of non–animal-stabilized hyaluronic acid on facial aging, among other important topics. Also featured: Expert commentary from Steering Committee Member Mark L. Jewell, MD!
|
|
|
• Dynamic Slide Library
New slides exploring the efficacy of non–animal-stabilized hyaluronic acid, hyaluronic acid gel, and bovine and porcine collagen for the optimal treatment of nasolabial folds.
|
Slides of the Month
|
|
|
|
|
|
|
|
Hyaluronic Acid Versus Bovine Collagen for Nasolabial Folds
|
|
This multicenter, double-masked, randomized, within-subject study compared the efficacy ...
|
|
View
all Slides |
|
|
|
|
|
|
Mean Improvement from Baseline: Investigators’ Assessment
|
|
In this study, 439 patients (aged ≥30 years) who had moderate or severe (fully visibl...
|
|
View
all Slides |
|
|
|
|
|
|
Mean Improvement from Baseline: Patients’ Assessment
|
|
In this study, 439 patients (aged ≥30 years) who had moderate or severe (fully visibl...
|
|
View
all Slides |
|
|
|
|
|
|
NASHA Versus Porcine Collagen for Nasolabial Folds
|
|
This randomized, multicenter, within-subject, noninferiority study compared the efficacy...
|
|
View
all Slides |
|
|
|
|
|
|
Wrinkle Scale After Optimal Cosmetic Correction
|
|
This randomized, multicenter, within-subject, noninferiority study compared the efficacy...
|
|
View
all Slides |
|
In The News
Researchers Use New Tools To Combat Skin Cancer
Jul 26, 2008 -- There's something new under the sun at South Dakota State University: Researchers are working with molecules that protect against skin cancer and may even help undo the sun's damage. Distinguished professor Chandradhar Dwivedi, head of the Pharmaceutical Sciences Department in the College of Pharmacy at SDSU, said the work could be commercialized within 10 years. "We are looking at a number of molecules that can be used with sunscreen or without sunscreen.
|
Clinical Trial Concluded For New Wrinkle Treatment
Jul 25, 2008 -- Gel-Del Technologies, a St. Paul, Minnesota based biomedical device company announced that it has concluded clinical trials of CosmetaLife, a dermal filler injection that company officials say holds potential to be a more effective alternative to currently available treatments for deep lines and wrinkles that activates a more natural skin correction. The company began clinical trials of CosmetaLife, a gel-particle product for injection to correct wrinkles, at six U.S.
|
Clinical Trial Concluded For New Wrinkle Treatment
Jul 25, 2008 -- Gel-Del Technologies, a St. Paul, Minnesota based biomedical device company announced that it has concluded clinical trials of CosmetaLife, a dermal filler injection that company officials say holds potential to be a more effective alternative to currently available treatments for deep lines and wrinkles that activates a more natural skin correction. The company began clinical trials of CosmetaLife, a gel-particle product for injection to correct wrinkles, at six U.S.
|
PEAK Surgical Receives 510(k) Clearance To Market PEAK(R) Surgery System For Use In General Surgery
Jul 25, 2008 -- PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system based on a proprietary technology, announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its PEAK(R) Surgery System for use in general surgery. The PEAK Surgery System combines the PULSAR(TM) Generator, which supplies pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade(TM) 4.
|
|
|
|
Login
Please enter both email and password to log in
Participate in our
Online polls
|
|